Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02607865

Public ClinicalTrials.gov record NCT02607865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to investigate efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02607865
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,864 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2016
Primary completion
Feb 13, 2017
Completion
Mar 27, 2018
Last update posted
Jul 19, 2022

2016 – 2018

United States locations

U.S. sites
93
U.S. states
36
U.S. cities
84
Facility City State ZIP Site status
Novo Nordisk Investigational Site Anniston Alabama 36207
Novo Nordisk Investigational Site Birmingham Alabama 35211
Novo Nordisk Investigational Site Tuscumbia Alabama 35674
Novo Nordisk Investigational Site Glendale Arizona 85308
Novo Nordisk Investigational Site Little Rock Arkansas 72212
Novo Nordisk Investigational Site Carmichael California 95608
Novo Nordisk Investigational Site Coronado California 92118
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Los Alamitos California 90720
Novo Nordisk Investigational Site Palm Springs California 92262
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Denver Colorado 80220
Novo Nordisk Investigational Site Kissimmee Florida 34741
Novo Nordisk Investigational Site New Port Richey Florida 34652
Novo Nordisk Investigational Site Palm Harbor Florida 34684
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Port Charlotte Florida 33952
Novo Nordisk Investigational Site Spring Hill Florida 34609
Novo Nordisk Investigational Site Tampa Florida 33607
Novo Nordisk Investigational Site Marietta Georgia 30060
Novo Nordisk Investigational Site Perry Georgia 31069
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Meridian Idaho 83646
Novo Nordisk Investigational Site Gurnee Illinois 60031
Novo Nordisk Investigational Site Peoria Illinois 61602
Novo Nordisk Investigational Site Peoria Illinois 61603
Novo Nordisk Investigational Site Avon Indiana 46123
Novo Nordisk Investigational Site Park City Kansas 67219
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Paducah Kentucky 42001
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Natchitoches Louisiana 71457-5881
Novo Nordisk Investigational Site Shreveport Louisiana 71105
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Flint Michigan 48532
Novo Nordisk Investigational Site Sterling Heights Michigan 48310-3503
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site Butte Montana 59701-1652
Novo Nordisk Investigational Site Teaneck New Jersey 07666
Novo Nordisk Investigational Site Trenton New Jersey 08611
Novo Nordisk Investigational Site Albuquerque New Mexico 87102
Novo Nordisk Investigational Site New Windsor New York 12553
Novo Nordisk Investigational Site Rochester New York 14607
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Charlotte North Carolina 28277
Novo Nordisk Investigational Site High Point North Carolina 27265
Novo Nordisk Investigational Site Statesville North Carolina 28625
Novo Nordisk Investigational Site Whiteville North Carolina 28472
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Fargo North Dakota 58104
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Cincinnati Ohio 45236
Novo Nordisk Investigational Site Columbus Ohio 43203
Novo Nordisk Investigational Site Columbus Ohio 43213
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Maumee Ohio 43537
Novo Nordisk Investigational Site Toledo Ohio 43623
Novo Nordisk Investigational Site Norman Oklahoma 73069
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737
Novo Nordisk Investigational Site Jersey Shore Pennsylvania 17740
Novo Nordisk Investigational Site McMurray Pennsylvania 15317
Novo Nordisk Investigational Site Gaffney South Carolina 29341
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Pelzer South Carolina 29669
Novo Nordisk Investigational Site Summerville South Carolina 29485
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352
Novo Nordisk Investigational Site Humboldt Tennessee 38343
Novo Nordisk Investigational Site Jackson Tennessee 38305
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Dallas Texas 75226
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Houston Texas 77074
Novo Nordisk Investigational Site Houston Texas 77081
Novo Nordisk Investigational Site Longview Texas 75605
Novo Nordisk Investigational Site Plano Texas 75093
Novo Nordisk Investigational Site San Antonio Texas 78209
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Waco Texas 76710
Novo Nordisk Investigational Site Murray Utah 84123
Novo Nordisk Investigational Site South Burlington Vermont 05403
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Spokane Washington 99218
Novo Nordisk Investigational Site Milwaukee Wisconsin 53202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02607865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2022 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02607865 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →